10 results
DRS
NEXI
Neximmune Inc
14 Dec 20
Draft registration statement
12:00am
on the treatment of chronic renal disease. Prior to that, he served as Chief Executive Officer of RegenMed Therapeutics. He served as Chief Scientific
10-K
2020 FY
NEXI
Neximmune Inc
31 Mar 21
Annual report
4:02pm
focused on the treatment of chronic renal disease. Prior to that, he served as Chief Executive Officer of RegenMed Therapeutics. He served as Chief
S-1
8hl md2yuuz
19 Jan 21
IPO registration
4:38pm
DRS/A
5jnylirposl
15 Jan 21
Draft registration statement (amended)
12:00am
424B4
buji0midljc 8q
16 Feb 21
Prospectus supplement with pricing info
4:38pm
S-1/A
fr0d48iv
8 Feb 21
IPO registration (amended)
7:29am
- Prev
- 1
- Next